Work

A phase I/II trial of VX15/2503 in children, adolescents, and young adults with relapsed or refractory solid tumors (ADVL1614).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e21519

Authors: Emily Gustava Greengard, Robin Lesley Williams, Xiaowei Liu, Olga Militano, Terrence Lee Fisher, Elizabeth E. Evans, Charles G. Minard, Joel M. Reid, Stephan D. Voss, Stacey L. Berg, Elizabeth Fox, Brenda Weigel

Institutions: University of Minnesota, Children's Oncology Group, New York Medical College, Vaccinex (United States), Baylor College of Medicine, Mayo Clinic, Boston Children's Hospital, Children's Hospital of Philadelphia

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2970448347

Cites:

Cited by: 3

Related to: 10